References for this Section
1. Hanon O, Forette F. Treatment of hypertension and prevention of dementia. Alzheimer's and Dementia 2005; 1:30-7.
2. Sheppard JE. Effects of cognition, mood and degenerative brain diseases. J Am Pharm Assoc 2001; 41(2):221-8.
3. Espeland MA, Rapp SR, Shumaker SA Brunner R, Manson JE, Sherwin, BB et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291:2959-68.
4. Isbir T, Agachan B, Yilmaz, H, Aydin M, Kara, I Eker E, Eker D. Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease. Am J Alzheimers Dis Other Demen 2001; 16:77-81.
5. Kearney PM, Whelton M, Reynolds N et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455):217-23.
6. Sowers, JR. Diabetes in elderly and in women: cardiovascular risks. Cardiol Clin 2004; 22:541-51.
7. Gustafson D, Lissner L, Begtsson C, Bjorkelund C, Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004; 63:1876-81.
8. Seshadri S, Wolf PA. Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurology Jan; 2(1):11.
9. Qui C, von Strauss E, Fastbom J, Winbald B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow up study. Arch Neurol 2003; 60(2):223-8.
10. van Duijin CM, Clayton D et al. Familial aggression of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. International Journal of Epidemilogy. 1991; 20(2):S13.
11. Slooter AJ, Cruts M, Hofman A, Koudstaal PJ, van der Kuip D, de Ridder MA et al. The impact of APOE on myocardial infarction, stroke and dementia: the Rotterdam Study. Neurology 2004; 62:1196-8.
